COMT and androgen insensitivity syndrome: If further studies can confirm the association, we found with the combination of MTHFR and COMT low activity variants, this body of evidence could be used to support investigation of potential therapeutic approaches such as folate and melatonin supplementation or other modalities targeting the MTHFR and COMT pathways to reduce the risk of AIS progression.